Archive for the ‘Vermont’ Category

Peak Pitch: Elevator pitches with skis

Friday, February 19th, 2010

Reports coming from northern New England this winter have been somewhat disappointing. Let’s face it, with minimal new snow since Christmas, ski conditions haven’t been great. In fact, until the little boost earlier this week, there were a few too many sites listing their snow as “granular.” Translation, look out for the ice.

Yet, ski reports have been just ducky compared with reports from people trying to get the money to launch new companies in the past 18 months. So, somehow it must make sense that you would bring the world of finance to the ski slopes.

FreshTracks Capital plans to pair investors and entrepreneurs in a ski-lift pitch, with the entrepreneurs getting the few minutes in the chair ride to the summit to get through their talking points. The event is slated for March 3 at Bolton Valley in Vermont. (At least they are reporting “packed powder.”) Yes, there have been similar approaches in the past, events along the lines of speed dating.

Think of the possibilities, though. Do you really want to be the risk-averse entrepreneur chugging up the bunny slope on the magic carpet ride? Even worse would be the entrepreneur who punctuates his pitch with a run down a double black diamond. Maybe he could use a lesson in risk management. Or, if the investor doesn’t seem receptive to a pitch, the entrepreneur can bid them adieu with the old stage line, “Break a leg.”

NewsFlash Roundup: AMAG, General Dynamics; Marine Renewable Energy Center

Wednesday, July 1st, 2009

In today’s NewsFlash Roundup, General Dynamics gets $10 million for grenade launchers and AMAG’s kidney drug gets FDA approval.

Boston life science center pulls in $350M loan

The center, which is intended to serve as a world-class research and collaboration hub for life sciences companies and the Harvard University-affiliated teaching hospitals, was completed last year. As of the beginning of 2009, the center was nearing its capacity.

AMAG wins FDA approval for kidney drug

AMAG Pharmaceuticals Inc. has won U.S. Food and Drug Administration approval for its drug, called Feraheme, to treat chronic kidney disease. The Lexington-based company’s drug is an injection designed to be used as an iron replacement therapy to fight anemia in patients with kidney disease. The drug can be used by patients who are on or off dialysis.

DOE awards $750K to Marine Renewable Energy Center

The center’s Marine Renewable Energy Center will receive $750,000 from the U.S. Department of Energy’s fiscal year 2010 budget, said John Miller, director of operations for the ATMC and head of the marine center. The appropriation is on top of $1 million in DOE grant funding the marine center will receive to spur academic research efforts and support small marine technology companies. (more…)

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.